Endya High

Works (1)

Updated: July 5th, 2023 14:44

2020 article

Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs

High, E. J., Linder, K. E., Mamo, L. B., Levy, B. J., Herrmann, I., & Bizikova, P. (2020, April 19). Veterinary Dermatology, Vol. 31, p. 330.

By: E. High n, K. Linder n, L. Mamo n, B. Levy n, I. Herrmann n  & P. Bizikova n 

MeSH headings : Animals; Dermatitis, Atopic / drug therapy; Dermatitis, Atopic / veterinary; Dog Diseases / drug therapy; Dogs; Erythema Multiforme / diagnosis; Erythema Multiforme / drug therapy; Erythema Multiforme / veterinary; Female; Pyrimidines / therapeutic use; Skin Diseases / drug therapy; Skin Diseases / veterinary; Sulfonamides / therapeutic use; Treatment Outcome
topics (OpenAlex): Autoimmune Bullous Skin Diseases; Mast cells and histamine; Skin and Cellular Biology Research
TL;DR: Oclacitinib could be considered as a fast-acting and effective treatment option for HKEM in dogs with a complete remission of clinical signs observed in 12 and seven weeks in cases 1 and 2. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: May 8, 2020

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.